Developments in the treatment of benign essential blepharospasm

Purpose of review To review new developments in the medical and surgical treatment options for benign essential blepharospasm (BEB). Recent findings Botulinum toxin injections remain the mainstay treatment for BEB with several formulations currently commercially available. Reports in the medical literature support photochromatic modulation for the symptoms of photophobia, as well as oral medications and surgical myectomy for control of the motor signs of eyelid protractor spasm. Summary Although there remains no cure for BEB, several treatment options are available to effectively manage the signs and symptoms of the condition.